Skip to main content

Hydroxychloroquine annual eye exam

CBE ID
0585
1.4 Project
EENT Endorsement Maintenance
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Full Year 2014
Is Under Review
No
1.3 Measure Description

This measure identifies the percentage of patients with Rheumatoid Arthritis who received hydroxychloroquine during the measurement year and had a fundoscopic examination during the measurement year or in the year prior to the measurement year

    • 1.14 Numerator

      Patients in the denominator who have undergone a retinal eye exam or who have an E&M visit with an eye care professional during the measurement year

    • 1.15 Denominator

      Patients with a diagnosis of rheumatoid arthritis who are at high risk for hydroxychloroquine ocular complications and were prescribed at least a 292-day supply of hydroxychloroquine during the measurement year, excluding those with a prior history of blindness

    • Exclusions

      Blindness

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed EENT Endorsement Maintenance Project 2014
      Initial Endorsement
      Last Updated
      Removal Date